Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion type Assertion NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_head.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion description "[In�vitro and in�vivo pharmacologic targeting of KDM1A using tranylcypromine analogs active in the nanomolar range phenocopied Kdm1a knockdown in both murine and primary human AML cells exhibiting MLL translocations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_provenance.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion evidence source_evidence_literature NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_provenance.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion SIO_000772 22464800 NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_provenance.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion wasDerivedFrom befree-2016 NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_provenance.
- NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_assertion wasGeneratedBy ECO_0000203 NP971621.RASDrdEQzI9yQR7WjObqI2rIMHTGQjkKgM5fO6I7nKGnQ130_provenance.